NDC 71335-2425-01 - OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-2425
- Requested NDC
- 71335-2425-01
- Package NDCs from labels
- 71335-2425-1, 71335-2425-2, 71335-2425-3, 71335-2425-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-05-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-05-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2425-1 | OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET | 90 | 2 | |
| 71335-2425-2 | OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET | 30 | 2 | |
| 71335-2425-3 | OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | 60 in 1 BOTTLE | TABLET | 60 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-2425 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 1 | Current NDC, 3 package rows | 20240702_78eb9041-a738-4056-8705-8c1dd13a4da4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Radialgin | CITRUS LIMONUM, FUCUS VESICULOSUS, HYDRANGEA ARBORESCENS, SODIUM ALGINATE, NATRUM MURIATICUM, PHOSPHORUS, AGATE, RADIUM BROMATUM, X RAY | Nutritional Specialties, Inc. | f1414ae2-4068-4076-bf11-b57a34ba5df2 | 2023-04-12 | Warnings | ETJ7Z6XBU4 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 69c41abb-75f4-429b-905a-1ce967924aee | 2023-04-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 3464be28-5bab-4642-9d9b-8b425822dd07 | 2023-04-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Exelan Pharmaceuticals, Inc. | c40b15ec-6083-4778-bca8-3e895e5694e1 | 2023-03-28 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Silicea | SILICON DIOXIDE | Boiron | 86d34721-7dfc-bf91-e053-2991aa0a70ae | 2023-03-27 | ETJ7Z6XBU4 | |
| NS Support | BERBERIS VULGARIS, CIMICIFUGA RACEMOSA, CINCHONA OFFICINALIS, COLOCYNTHIS, LEDUM PALUSTRE, RANUNCULUS BULBOSUS, AESCULUS HIPPOCASTANUM, CUPRUM ACETICUM, NADIDUM, NATRUM OXALACETICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, THIAMINUM HYDROCHLORICUM, ALPHA-LIPOICUM ACIDUM, AMMONIUM MURIATICUM, CARTILAGO SUIS, DISCUS INTERVERTEBRALIS SUIS, PICRICUM ACIDUM, SILICEA, ARGENTUM METALLICUM, CALCAREA PHOSPHORICA, FUNICULUS UMBILICALIS SUIS, GLANDULA SUPRARENALIS SUIS, GNAPHALIUM POLYCEPHALUM, | Dr. Donna Restivo DC | 807fd9cf-13d1-4173-a6da-180f89b67cf2 | 2023-03-15 | Warnings | ETJ7Z6XBU4 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | afdf1170-25a0-496d-b293-36ee0db2cd1e | 2023-03-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| CAPTOPRIL AND HYDROCHLOROTHIAZIDE | CAPTOPRIL AND HYDROCHLOROTHIAZIDE | Rising Pharma Holdings, Inc. | 0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e | 2023-02-21 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Perfect Sleep | ADENOSINUM TRIPHOSPHORICUM DINATRUM, PANTOTHENIC ACID, PINEAL GLAND (SUIS), SARCOLACTICUM ACIDUM, UBIDECARENONUM, L-TRYPTOPHAN, MELATONIN, PYRROLE, ARSENICUM ALBUM, AVENA SATIVA, CHAMOMILLA, COFFEA CRUDA, MERCURIUS CORROSIVUS, PASSIFLORA INCARNATA, SILICEA, ZINCUM VALERIANICUM, DYSENTERY BACILLUS, GAERTNER BACILLUS | Deseret Biologicals, Inc. | d29af0e7-0d04-47e3-9a50-d99c7e14b44d | 2023-02-20 | Warnings | ETJ7Z6XBU4 |
| Silicea | SILICON DIOXIDE | Boiron | 86d395ec-3c3b-5e5f-e053-2a91aa0a3f9c | 2023-02-20 | ETJ7Z6XBU4 | |
| EyeClear Pro | CALC CARB, CALC FLUOR, CAUSTICUM, CINERARIA, EUPHRASIA, NAPHTHALINUM, NAT MUR, PHOS, QUASSIA, SILICEA | Silver Star Brands | f4d4943b-cb78-aa71-e053-2a95a90ac638 | 2023-02-16 | Warnings | ETJ7Z6XBU4 |
| CellTropin | ARGININE, GINKGO BILOBA, HYPOPHYSIS SUIS, SILICEA, ASTRAGALUS EXCAPUS | Micro Balance Health Products LLC | 502d3ffa-bbf4-403a-9fad-b6b229f36a8c | 2023-02-14 | Warnings | ETJ7Z6XBU4 |
| Mineral Sunscreen SPF 50 | ZINC OXIDE TITANIUM DIOXIDE | Topiderm, Inc. | 3a637542-0f79-47ae-815d-84d0036c737a | 2023-02-13 | Warnings | 15FIX9V2JP |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | ef100fa1-dd63-4287-8543-480a82ace168 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f1ef2a2c-7b8d-4127-8f47-29e430fba70b | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 54224596-325d-473e-adb5-1c86857aba34 | 2023-02-04 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c1052d38-fd75-40c2-a685-0e889009be0b | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 84dba61d-cae2-4f21-9a9e-3088f356f838 | 2023-02-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | c4fe84e3-c291-4220-95c1-a2bd02b1e134 | 2023-02-01 | Warnings, Adverse reactions | 0J48LPH2TH |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | 34703033-14c4-459c-8b8f-2f2e1145aff7 | 2023-01-30 | Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.